Name | Number of supported studies | Average coverage | |
---|---|---|---|
platelet | 9 studies | 32% ± 12% | |
epithelial cell | 5 studies | 40% ± 18% | |
enteroendocrine cell | 4 studies | 35% ± 9% | |
endothelial cell | 4 studies | 21% ± 5% | |
GABAergic neuron | 4 studies | 35% ± 11% | |
glutamatergic neuron | 4 studies | 40% ± 15% | |
goblet cell | 4 studies | 21% ± 5% | |
oligodendrocyte | 4 studies | 17% ± 1% | |
pancreatic A cell | 3 studies | 34% ± 15% | |
megakaryocyte | 3 studies | 36% ± 16% | |
retinal cone cell | 3 studies | 40% ± 17% | |
fibroblast | 3 studies | 24% ± 3% | |
interneuron | 3 studies | 37% ± 18% | |
astrocyte | 3 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1829.17 | 1445 / 1445 | 100% | 12.63 | 183 / 183 |
ovary | 100% | 2275.25 | 180 / 180 | 100% | 17.41 | 430 / 430 |
prostate | 100% | 2063.58 | 245 / 245 | 100% | 44.41 | 502 / 502 |
brain | 100% | 2445.44 | 2642 / 2642 | 100% | 22.56 | 704 / 705 |
kidney | 100% | 2454.94 | 89 / 89 | 100% | 20.86 | 897 / 901 |
breast | 100% | 1812.26 | 459 / 459 | 99% | 28.10 | 1112 / 1118 |
lung | 100% | 1633.45 | 577 / 578 | 100% | 13.40 | 1150 / 1155 |
intestine | 100% | 1918.36 | 966 / 966 | 99% | 15.22 | 523 / 527 |
pancreas | 100% | 2707.06 | 328 / 328 | 99% | 12.63 | 176 / 178 |
thymus | 100% | 2234.56 | 653 / 653 | 99% | 21.42 | 597 / 605 |
stomach | 100% | 1516.30 | 359 / 359 | 99% | 15.01 | 282 / 286 |
adrenal gland | 100% | 2183.27 | 258 / 258 | 98% | 18.31 | 226 / 230 |
bladder | 100% | 1685.57 | 21 / 21 | 97% | 13.86 | 490 / 504 |
uterus | 100% | 1714.86 | 170 / 170 | 96% | 11.17 | 440 / 459 |
liver | 100% | 1950.88 | 226 / 226 | 94% | 10.33 | 380 / 406 |
skin | 100% | 1606.55 | 1808 / 1809 | 89% | 11.25 | 419 / 472 |
adipose | 100% | 1643.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1986.91 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2282.80 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1105.83 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.41 | 1 / 1 |
heart | 97% | 2251.14 | 838 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 9.03 | 41 / 45 |
eye | 0% | 0 | 0 / 0 | 68% | 6.83 | 54 / 80 |
peripheral blood | 40% | 310.94 | 368 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 38% | 1.97 | 11 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0008150 | Biological process | biological_process |
GO_0016042 | Biological process | lipid catabolic process |
GO_0050482 | Biological process | arachidonic acid secretion |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0004623 | Molecular function | phospholipase A2 activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PLA2G12A |
Protein name | Phospholipase A2, group XIIA, isoform CRA_b (cDNA PSEC0079 fis, clone NT2RP2004049, highly similar to Group XII secretory phospholipase A2) (cDNA, FLJ93563, Homo sapiens phospholipase A2, group XII (PLA2G12), mRNA) Phospholipase A2 group XIIA (Phospholipase A2, group XIIA, isoform CRA_d) Phospholipase A2 group XIIA (Phospholipase A2, group XIIA, isoform CRA_a) Group XIIA secretory phospholipase A2 (GXII sPLA2) (sPLA2-XII) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 12A) |
Synonyms | hCG_21046 UNQ2519/PRO6012 PLA2G12 FKSG38 |
Description | FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Does not exhibit detectable activity toward sn-2-arachidonoyl- or linoleoyl-phosphatidylcholine or -phosphatidylethanolamine. . |
Accessions | Q542Y6 ENST00000243501.10 D6RBP5 A0A0C4DGC6 Q9BZM1 ENST00000502283.1 ENST00000507961.1 |